Another activist letter is no real surprise. GSK has failed to release pertinent information on the Consumer Healthcare spinoff & “New GSK”; As more letters emerge the Value gap is set to narrow.
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.